Toxicity and survival associated with IV/IP chemotherapy following neoadjuvant chemotherapy and interval debulking surgery for epithelial ovarian, fallopian tube, and primary peritoneal cancer

被引：0
|
作者：
Rios-Doria, E. [1 ]
Pezzillo, M. [1 ]
Ulm, M. A. [2 ]
Tillmanns, T. [2 ]
机构：
[1] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[2] Univ Tennessee, West Canc Ctr, Memphis, TN USA
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.157
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
269
引用
收藏
页码：127 / 128
页数：2
相关论文
共 50 条
  • [41] Comparative analysis of neoadjuvant chemotherapy versus primary debulking surgery in advanced epithelial ovarian cancer
    Sirop, S. J.
    Saha, S.
    Iddings, D.
    Ghanem, M.
    Dutt, N.
    Metz, J.
    Wilson, D.
    Weise, D.
    Arora, M. L.
    Singh, T.
    Eilender, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] Primary debulking surgery and neoadjuvant chemotherapy in the treatment of advanced epithelial ovarian carcinoma
    Seward, Shelly M.
    Winer, Ira
    CANCER AND METASTASIS REVIEWS, 2015, 34 (01) : 5 - 10
  • [43] Primary debulking surgery and neoadjuvant chemotherapy in the treatment of advanced epithelial ovarian carcinoma
    Shelly M. Seward
    Ira Winer
    Cancer and Metastasis Reviews, 2015, 34 : 5 - 10
  • [44] Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer
    Vergote, IB
    De Wever, I
    Decloedt, J
    Tjalma, W
    Van Gramberen, M
    van Dam, P
    SEMINARS IN ONCOLOGY, 2000, 27 (03) : 31 - 36
  • [45] Neoadjuvant Chemotherapy or Primary Debulking Surgery for Stage IIIC Ovarian Cancer
    Copur, Mehmet Sitki
    Gauchan, Dron
    Ramaekers, Ryan
    Crockett, David
    Clark, Douglas
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) : 802 - 802
  • [46] Factors that predict optimal debulking at interval cytoreductive surgery after neoadjuvant chemotherapy in epithelial ovarian cancer
    Boccaccio, R. B.
    Crim, A. K.
    Osborn, K.
    Ding, K.
    Moore, K. N.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 82 - 82
  • [47] The management of epithelial ovarian cancer: neoadjuvant chemotherapy and interval surgery
    Allen, D. G.
    SOUTHERN AFRICAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2010, 2 (02) : 67 - 68
  • [48] Intraperitoneal versus intravenous chemotherapy after neoadjuvant chemotherapy and optimal interval debulking for epithelial ovarian cancer
    Abu Shahin, F.
    Seamon, L. G.
    Goksedef, B. P.
    Catenacci, M.
    Carlson, M. J.
    Green, A. E.
    O'Malley, D. M.
    Rose, P. G.
    Belinson, J. L.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S138 - S139
  • [49] Minimally invasive interval debulking surgery after neoadjuvant chemotherapy for ovarian cancer
    Seagle, B. L. L.
    Yang, J.
    Kocherginsky, M.
    Shahabi, S.
    GYNECOLOGIC ONCOLOGY, 2018, 149 (03) : 629 - 630
  • [50] Laparoscopic interval debulking surgery for advanced ovarian cancer after neoadjuvant chemotherapy
    Jorgensen, K.
    Melamed, A.
    Bradford, L.
    Wang, V.
    Chang, H.
    Rauh-Hain, J. A.
    Schorge, J.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 49 - 50
12345